ADRB2 and graft versus host disease: The strong, naturally occurring immunosuppressive potential of β‐AR signalling is consistent with our observations that adrenergic stress or addition of β‐AR agonists can suppress graft versus host disease (GVHD) following allogeneic bone marrow transplantation (BMT).34, 35, 36